Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015.
Daly M, Pilarski R, Axilbund J, Berry M, Buys S, Crawford B, Farmer M, Friedman S, Garber J, Khan S, Klein C, Kohlmann W, Kurian A, Litton J, Madlensky L, Marcom P, Merajver S, Offit K, Pal T, Rana H, Reiser G, Robson M, Shannon K, Swisher E, Voian N, Weitzel J, Whelan A, Wick M, Wiesner G, Dwyer M, Kumar R, Darlow S. Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015. Journal Of The National Comprehensive Cancer Network 2016, 14: 153-62. PMID: 26850485, DOI: 10.6004/jnccn.2016.0018.Peer-Reviewed Original ResearchConceptsGenetic/Familial High-Risk AssessmentHigh-risk assessmentOvarian cancer risk reductionGenetic testing criteriaNCCN Guidelines InsightsCancer risk reductionRisk of breastHereditary cancer syndromesCommon genetic mutationsOvarian cancer histologiesNCCN guidelinesMultigene testingPancreatic cancerOvarian cancerCancer histologyCancer syndromesGenetic testingBreastPanel meetingGenetic mutationsPersonal historySyndromeRisk reductionCancerManagement recommendations